Attendo AB (ATT) Fair Value & Analysis
Healthcare · SE · Market cap 16.0B SEK
Fair value as of: Jul 15, 2026
From 24 valuation models · updated 26 days ago
Fair value updated Jul 15, 2026, revised from kr 100.57 to kr 101.23 (+0.7%) since Jul 14, 2026. Share price +0.3% over the past month.
A solid business, currently priced close to our fair value.
What matters now
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
- A fairly wide model range (kr 72.98 to kr 153.23) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 15, 2026.
How to read this chart
60‑month range kr 17.67 – kr 122.70 · fair‑value band kr 72.98 – kr 153.23 · the kr 108.40 price screens above the kr 101.23 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 15, 2026.
Analysis
Attendo AB (ATT) currently trades at kr 108.40, while our model-based Fair Value estimate is kr 101.23, implying the stock looks roughly 6.6% fairly valued today. The Quality Score stands at 62/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Attendo AB generated revenue of 18.9B SEK at a net margin of 4.6%. Revenue declined 1.6% year over year. It earns a return on equity of 16.4%. Net debt stands at 15.2B SEK. Fundamentals as of Jul 15, 2026
Our scenario range runs from kr 72.98 (bear case) to kr 153.23 (bull case); at kr 108.40, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 10% below its 52-week high and 84% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at 11% fair-value upside, at -7%, ATT screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 24 models by family
Widest divergence: DCF Models (kr 228.59) versus Asset-Based (kr 25.68). Highest evidence: Growth DCF (80).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 15, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 59 · Market factors (momentum, volatility) 74
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Attendo AB (publ) provides health and care services in Scandinavia and Finland. The company offers nursing homes for people with dementia or somatic care requirements; home care services, including care, meals, cleaning, laundry, evening and night, and home health care services; and homes for people of various ages with a range of disabilities or care needs.
Full company description
Attendo AB (publ) provides health and care services in Scandinavia and Finland. The company offers nursing homes for people with dementia or somatic care requirements; home care services, including care, meals, cleaning, laundry, evening and night, and home health care services; and homes for people of various ages with a range of disabilities or care needs. It also provides day care, respite care and companion, meal and staffing services, as well as short term accommodation; personalized residential care for people with neuropsychiatric and psychosocial disorders; and runs family homes, crisis and emergency homes, HVB homes, dependency care, schools, and various forms of supportive housing. The company was founded in 1985 and is headquartered in Danderyd, Sweden.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Attendo AB reported revenue of kr 19.0B in FY2025 versus kr 12.9B in FY2021, a compound +10.2%/yr. Reported net income was kr 813M in FY2025, compounding +95.2%/yr from FY2021.
Watch ATT: get an alert when its fair value changes →
Peer Group
Medical Care Facilities · 262 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Care Facilities median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Insider activity: 45/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 15, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc HCA | $378.85 | $554.93 | +46% |
| Fresenius SE FRE | €41.73 | €32.15 | -23% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.58 SGD | 1.44 SGD | -44% |
| Tenet Healthcare Corporation THC | $194.91 | $338.05 | +73% |
| Rede D'Or São Luiz S.A RDOR3 | R$36.01 | R$47.31 | +31% |
| DaVita Inc DVA | $231.61 | $255.97 | +11% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,955 | ₹2,955 | -67% |
| Fresenius Medical Care AG FMS | $24.68 | $45.60 | +85% |
| Aier Eye Hospital Group 300015 | ¥8.68 | ¥7.67 | -12% |
Compare Attendo AB with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Attendo AB (ATT) overvalued or undervalued?
What is the fair value of ATT?
What is the quality score of ATT?
What is the revenue of Attendo AB (ATT)?
What is the net profit margin of ATT?
Does Attendo AB pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Attendo AB and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.